Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

An assessment of a rapid SARS-CoV-2 antigen test in Bangladesh

View ORCID ProfileZannat Kawser, Mohabbat Hossain, View ORCID ProfileSara Suliman, View ORCID ProfileShahin Lockman, View ORCID ProfileJesse Gitaka, View ORCID ProfileGama Bandawe, View ORCID ProfileRedwan Rahmat, Imrul Hasan, Abu Bakar Siddik, View ORCID ProfileMokibul Hassan Afrad, Mohammed Ziaur Rahman, Glenn Miller, View ORCID ProfileDavid R. Walt, View ORCID ProfileLouise C. Ivers, View ORCID ProfileRegina C. LaRocque, Jason B. Harris, View ORCID ProfileFirdausi Qadri
doi: https://doi.org/10.1101/2021.10.05.21264551
Zannat Kawser
1institute for developing Science and Health initiatives (ideSHi), Dhaka, Bangladesh
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Zannat Kawser
Mohabbat Hossain
1institute for developing Science and Health initiatives (ideSHi), Dhaka, Bangladesh
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sara Suliman
2Infectious Disease Immunologist, Division of Experimental Medicine, Zuckerberg San Francisco General Hospital, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Sara Suliman
Shahin Lockman
3Division of Infectious Diseases, Brigham and Women’s Hospital, Boston MA, USA
4Harvard T.H. Chan School of Public Health, Boston MA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Shahin Lockman
Jesse Gitaka
5Directorate of Research and Innovation, Mount Kenya University, Thika, Kenya
6Centre for Malaria Elimination, Mount Kenya University, Thika, Kenya
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Jesse Gitaka
Gama Bandawe
7Biological Sciences Department, Academy of Medical Sciences, Malawi University of Science and Technology, Thyolo, Malawi
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Gama Bandawe
Redwan Rahmat
1institute for developing Science and Health initiatives (ideSHi), Dhaka, Bangladesh
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Redwan Rahmat
Imrul Hasan
1institute for developing Science and Health initiatives (ideSHi), Dhaka, Bangladesh
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Abu Bakar Siddik
1institute for developing Science and Health initiatives (ideSHi), Dhaka, Bangladesh
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mokibul Hassan Afrad
8International Center for Diarrheal Disease Research, Bangladesh (icddr,b), Dhaka, Bangladesh
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Mokibul Hassan Afrad
Mohammed Ziaur Rahman
8International Center for Diarrheal Disease Research, Bangladesh (icddr,b), Dhaka, Bangladesh
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Glenn Miller
9Mass General Brigham Center for COVID Innovation, Boston, MA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David R. Walt
9Mass General Brigham Center for COVID Innovation, Boston, MA
10Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, MA
11Department of Pathology, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for David R. Walt
Louise C. Ivers
12Department of Global Health and Social Medicine, Harvard Medical School, Boston MA, USA
13MGH Center for Global Health, Massachusetts General Hospital, Boston MA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Louise C. Ivers
Regina C. LaRocque
13MGH Center for Global Health, Massachusetts General Hospital, Boston MA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Regina C. LaRocque
Jason B. Harris
13MGH Center for Global Health, Massachusetts General Hospital, Boston MA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Firdausi Qadri
8International Center for Diarrheal Disease Research, Bangladesh (icddr,b), Dhaka, Bangladesh
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Firdausi Qadri
  • For correspondence: fqadri@icddrb.org
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Early detection of SARS-CoV-2 infection is crucial to prevent the spread of the virus. In this study, we evaluated the performance of a commercial rapid antigen detection test, BD Veritor, and compared this (and another rapid test, Standard Q) against a gold-standard of nasopharyngeal (NP) swab tested by reverse transcription-polymerase chain reaction (RT-PCR) in prospectively-recruited adults in Dhaka, Bangladesh. We compared the sensitivity and specificity of the two rapid antigen tests against RT-PCR results in 130 symptomatic and 130 asymptomatic adults. In addition, we evaluated the suitability and ease-of-use of the BD Veritor test in a subsample of study participants (n=42) and implementers (n=5). The sensitivity of the BD Veritor rapid antigen test was 70% in symptomatic (95% confidence interval [CI]: 51-85%) and 87% (95% CI: 69-96%) in asymptomatic individuals with positive SARSCoV-2 RT-PCR, for overall sensitivity of 78% (95% CI: 66-88%). The sensitivity of the Standard Q rapid antigen test was 63% (95% CI: 44-80%) in symptomatic and 73% (95% CI: 54-87%) in asymptomatic individuals. One false positive in BD Veritor test (specificity 99.5) and no false positive in Standard Q tests were observed (specificity 100%). The BD Veritor rapid antigen test was 78% sensitive when compared with RT-PCR irrespective of the cycle threshold (Ct) levels in this evaluation in Bangladesh. The implementation evaluation data showed good acceptability in the field settings. This warrants large field evaluation as well as use of the rapid antigen test for quick assessment of SARS-CoV-2 for containment of epidemics in the country.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

We gratefully acknowledge the support of Mass General Brigham (MGB) Center for COVID Innovation for providing the BD Veritor plus analyzer antigen detection kits and the Massachusetts General Hospital (MGH) for facilitation of the work. We thank the Bill and Melinda Gates Foundation for support to icddr,b investigators. icddr,b is grateful to the Governments of Bangladesh, Canada, Sweden, and the United Kingdom for providing core/unrestricted support. The overall support of Fondation Merieux to ideSHi is acknowledeged. We would like to express our gratitude to the participants for taking part and the field site staff of ideSHi for their effort to accomplish the work.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The study was approved by the Research Review Committee (RRC) and Ethical Review Committee (ERC) of icddr,b (Protocol no: PR- 20042)

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • Email Adress: Zannat Kawser- zannatzkawser{at}gmail.com

    Mohabbat Hossain- mohabbat{at}ideshi.org

    Sara Suliman- ssuliman1{at}bwh.harvard.edu

    Shahin Lockman- shahin.lockman{at}gmail.com

    Jesse Gitaka- jgitaka{at}mku.ac.ke

    Gama Bandawe- gbandawe{at}must.ac.mw

    Redwan Rahmat- redwan{at}ideshi.org

    Mokibul Hassan Afrad- hassan.afrad{at}icddrb.org

    Mohammed Ziaur Rahman –mzrahman{at}icddrb.org

    Imrul Hasan- imrul{at}ideshi.org

    Abu Bakar Siddik- absiddik{at}ideshi.org

    Glenn Miller- GAMILLER{at}partners.org

    David R. Walt- dwalt{at}bwh.harvard.edu

    Louise C. Ivers- LIVERS{at}mgh.harvard.edu

    Regina C. LaRocque- RCLAROCQUE{at}mgh.harvard.edu

    Jason B. Harris- JBHARRIS{at}mgh.harvard.edu

    Firdausi Qadri- fqadri{at}icddrb.org

Data Availability

All the data related to this manuscript are confidential. Hence, we are not able to make it public until our manuscript gets published in a peer reviewed journal.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Back to top
PreviousNext
Posted October 07, 2021.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
An assessment of a rapid SARS-CoV-2 antigen test in Bangladesh
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
An assessment of a rapid SARS-CoV-2 antigen test in Bangladesh
Zannat Kawser, Mohabbat Hossain, Sara Suliman, Shahin Lockman, Jesse Gitaka, Gama Bandawe, Redwan Rahmat, Imrul Hasan, Abu Bakar Siddik, Mokibul Hassan Afrad, Mohammed Ziaur Rahman, Glenn Miller, David R. Walt, Louise C. Ivers, Regina C. LaRocque, Jason B. Harris, Firdausi Qadri
medRxiv 2021.10.05.21264551; doi: https://doi.org/10.1101/2021.10.05.21264551
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
An assessment of a rapid SARS-CoV-2 antigen test in Bangladesh
Zannat Kawser, Mohabbat Hossain, Sara Suliman, Shahin Lockman, Jesse Gitaka, Gama Bandawe, Redwan Rahmat, Imrul Hasan, Abu Bakar Siddik, Mokibul Hassan Afrad, Mohammed Ziaur Rahman, Glenn Miller, David R. Walt, Louise C. Ivers, Regina C. LaRocque, Jason B. Harris, Firdausi Qadri
medRxiv 2021.10.05.21264551; doi: https://doi.org/10.1101/2021.10.05.21264551

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (230)
  • Allergy and Immunology (507)
  • Anesthesia (111)
  • Cardiovascular Medicine (1264)
  • Dentistry and Oral Medicine (207)
  • Dermatology (148)
  • Emergency Medicine (283)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (538)
  • Epidemiology (10056)
  • Forensic Medicine (5)
  • Gastroenterology (502)
  • Genetic and Genomic Medicine (2486)
  • Geriatric Medicine (240)
  • Health Economics (482)
  • Health Informatics (1653)
  • Health Policy (757)
  • Health Systems and Quality Improvement (638)
  • Hematology (250)
  • HIV/AIDS (538)
  • Infectious Diseases (except HIV/AIDS) (11896)
  • Intensive Care and Critical Care Medicine (627)
  • Medical Education (255)
  • Medical Ethics (75)
  • Nephrology (269)
  • Neurology (2304)
  • Nursing (140)
  • Nutrition (354)
  • Obstetrics and Gynecology (458)
  • Occupational and Environmental Health (537)
  • Oncology (1259)
  • Ophthalmology (377)
  • Orthopedics (134)
  • Otolaryngology (226)
  • Pain Medicine (158)
  • Palliative Medicine (50)
  • Pathology (326)
  • Pediatrics (737)
  • Pharmacology and Therapeutics (315)
  • Primary Care Research (282)
  • Psychiatry and Clinical Psychology (2295)
  • Public and Global Health (4850)
  • Radiology and Imaging (846)
  • Rehabilitation Medicine and Physical Therapy (493)
  • Respiratory Medicine (657)
  • Rheumatology (289)
  • Sexual and Reproductive Health (241)
  • Sports Medicine (228)
  • Surgery (273)
  • Toxicology (44)
  • Transplantation (131)
  • Urology (100)